AR and pachyonychia congenita: In addition, as-designed Di-PP/AR-siRNA/DTX nanocomplexes effectively and selectively carried both DTX and AR-siRNA to PC tissues and cells, which further effectively downregulated AR expression and increased the therapeutic efficacy of DTX in PC.